The RR for the occurrence of respiratory disease in patients receiving Albiglutide was 0.93 (95% CI 0.791.10, p = 0.40) compared to other interventions
Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA (2024) Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide
TSND-201 for the Treatment of PTSDNeuroplastogen TSND-201 for the Treatment of PTSD Blake Mandell Blake Mandell 8moBlake Mandell shared thisWe're hiring for an Associate Director, Clinical Operations and a Director of Clinical Development (MD required)
Hormones TRT for men, FBHRT for women
Lloberas J, Muoz JP, Hernndez-lvarez MI, Cardona PJ, Zorzano A, Celada A